You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Details for Patent: 6,335,032


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,335,032
Title: Orally administrable solid dosage form
Abstract:An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
Inventor(s): Liebowitz; Stephen M. (Neshanic Station, NJ), Stupak; Elliot I. (West Caldwell, NJ), Chaudry; Imtiaz A. (North Caldwell, NJ), Vadino; Winston A. (Whitehouse Station, NJ), Bowen; Frank E. (Rutherford, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:09/518,871
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,335,032: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into the scope and claims to understand its validity, enforceability, and position within the patent landscape. This article will provide a detailed analysis of the scope and claims of United States Patent 6,335,032, highlighting key aspects and implications.

Patent Overview

United States Patent 6,335,032, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and the process of patent examination.

Claim Scope and Its Importance

The scope of claims in a patent is pivotal as it defines the boundaries of the invention and what is protected under the patent. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get allowed and may increase the risk of invalidation due to prior art or failure to meet the written description requirement[3].

Types of Claims

Patent claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The claims in a patent like 6,335,032 must be carefully crafted to ensure they are supported by the specification and do not overstep the boundaries of what is disclosed.

Written Description Requirement

The written description requirement is a critical aspect of patent law. The claims must be anchored to the embodiments described in the specification. If the claims are too broad and not adequately supported by the written description, they may be invalidated[3].

Abstract Idea Exception

Claims that cover abstract ideas are not patentable. The Supreme Court has established tests to determine whether a claim falls under this exception. For example, the Alice test is often used to assess whether a claim is directed to an abstract idea and, if so, whether it contains an inventive concept that transforms the abstract idea into a patentable invention[3].

Obviousness-Type Double Patenting (ODP)

In cases where multiple patents are derived from the same application or are continuations-in-part, obviousness-type double patenting (ODP) analysis is crucial. This ensures that the same invention is not patented multiple times, which could extend the patent term unfairly. The USPTO and courts strictly enforce ODP rules to prevent such abuses[1].

Patent Prosecution Process

The journey from a patent application to a granted patent involves several steps, including filing, examination, and potential appeals. If the patent examiner does not accept the claims as submitted, the applicant may need to amend the claims or appeal the decision. This process can take several years and involves significant costs[5].

Commercial Viability and Market Potential

Before pursuing a patent, it is essential to assess the commercial viability and market potential of the invention. This involves considering whether the invention is novel, nonobvious, enabled, and at risk of public disclosure or invention by others. The decision to file a patent application is often made in consultation with the inventor and based on these criteria[5].

Patent Landscape and Trends

Understanding the broader patent landscape is vital. The USPTO classifies patents into various technology areas, which can help in analyzing trends and the competitive environment. For instance, in 2018, electrical and mechanical engineering patents made up about 60% of USPTO patents granted to U.S. inventors, indicating a strong focus in these areas[4].

Geographic and Technological Classification

Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification, which includes 35 International Patent Classification (IPC) technical fields. This classification helps in understanding the technological area in which the patent resides and its relevance to global trends[4].

Costs and Financial Considerations

The cost of obtaining and maintaining a patent is significant. Drafting and filing a U.S. non-provisional patent application can cost between $8,000 and $20,000, with additional costs incurred during the prosecution process and after the patent issues. International patents can be even more expensive[5].

Grace Period and Public Disclosure

In the U.S., there is a one-year grace period for filing a patent application after an enabling public disclosure. However, in most foreign countries, there is no such grace period, and public disclosure can immediately bar patent protection. This highlights the importance of timely filing and strategic management of public disclosures[5].

Key Takeaways

  • Claim Scope: The scope of claims must be carefully defined to avoid invalidation risks.
  • Written Description: Claims must be anchored to the embodiments described in the specification.
  • Abstract Idea Exception: Claims covering abstract ideas are not patentable unless they contain an inventive concept.
  • ODP Analysis: Essential for preventing the same invention from being patented multiple times.
  • Commercial Viability: Assessing market potential is crucial before filing a patent application.
  • Patent Landscape: Understanding the broader technological and geographical trends is vital.
  • Costs: Obtaining and maintaining a patent involves significant financial investment.

FAQs

Q: What is the importance of the written description requirement in patent claims? A: The written description requirement ensures that the claims are supported by the embodiments described in the specification, preventing overly broad claims that could be invalidated.

Q: How does the abstract idea exception impact patent claims? A: The abstract idea exception prevents claims that cover abstract ideas from being patented unless they contain an inventive concept that transforms the abstract idea into a patentable invention.

Q: What is obviousness-type double patenting (ODP), and why is it important? A: ODP analysis prevents the same invention from being patented multiple times, ensuring that the patent term is not unfairly extended.

Q: What are the key factors to consider before filing a patent application? A: Factors include the novelty, nonobviousness, enablement, risk of public disclosure, and commercial viability of the invention.

Q: How do geographic and technological classifications impact patent analysis? A: These classifications help in understanding the technological area and global trends, allowing for a more informed analysis of the patent's position within the broader patent landscape.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation
  5. Intellectual Property Protection - KU Office of Research

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,335,032

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,335,032

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 008977 ⤷  Try for Free
Australia 1668301 ⤷  Try for Free
Australia 2199199 ⤷  Try for Free
Austria 234103 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.